Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00130221 · ClinicalTrials.gov registry record · Phase 1
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
A Phase 1 study of Sepsis and Pneumonia, sponsored by Cook County Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT00130221: Completed Phase 1 study of Sepsis and Pneumonia, sponsored by Cook County Health.
NCT00130221 is a Phase 1 study of Sepsis and Pneumonia that has completed, run by Cook County Health. The registered enrollment target is 208 participants, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00130221, a Phase 1 study of Sepsis and Pneumonia, has completed, sponsored by Cook County Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cleansed with soap and water. However, preliminary data from a previous study at Rush University Medical Center showed that a chlorhexidine (CHG)-impregnated cloth (2% CHG Antiseptic Cloth system, Sage Products, Inc.) decreased skin bacteria and may lessen bacteria in the blood stream. The 2% CHG Antiseptic Cloth system is a non-irritating, no-rinse, cleansing and moisturizing product that contains 2% chlorhexidine gluconate. The goal of this proposed study is to further evaluate the effectiveness of the 2% CHG Antiseptic Cloth system compared with soap and water in cleansing the skin and preventing bacteria from entering the bloodstream.
Primary Outcome
Weekly culture of central line insertion sites
Conditions Studied
Interventions
- DRUG 2% chlorhexidine gluconate impregnated cloth
- OTHER Daily bathing with Bar soap
Study Locations (1)
Illinois
- John H. Stroger Hospital of Cook County - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-07-26 |
| Phase | Phase 1 |
What the finished NCT00130221 record still lists
NCT00130221 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 6,562-participant average among 90 other Sepsis trials with a reported enrollment target (97% lower).
The record links to 6 conditions, with Sepsis appearing as the primary indexed condition, and to 2 interventions - of which 2% chlorhexidine gluconate impregnated cloth is the first listed.
NCT00130221 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00130221 about?
NCT00130221 is a clinical study titled "Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections". Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cle...
What is the current status of trial NCT00130221?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 208 participants. The study started on 2005-06. Estimated completion is 2006-07-26.
What conditions does trial NCT00130221 study?
This clinical trial studies the following conditions: Sepsis, Pneumonia, Urinary Tract Infection, Bacteremia, Nosocomial Infection.
What interventions are being tested in trial NCT00130221?
The interventions under investigation include: 2% chlorhexidine gluconate impregnated cloth (DRUG), Daily bathing with Bar soap (OTHER).
Who is sponsoring clinical trial NCT00130221?
This trial is sponsored by Cook County Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00130221 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00130221's enrollment target sits among peer trials
208 41st of 90 higher than 50 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
RECRUITING · Phase 1
-
Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
ACTIVE NOT RECRUITING · Phase 1
-
Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance
COMPLETED · Phase 1
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
-
Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
COMPLETED · Phase 1
-
The APS Phenotyping Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia